| RS1586422427 |
SFTPC
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS1586426486 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586426507 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS1586430684 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS1586430715 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS1586431452 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS1586431903 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS1586432203 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1586437186 |
CHD7
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1586440484 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586440620 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586444410 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586444636 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1586446057 |
NDRG1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1586446101 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586446578 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586449004 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS1586451506 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586451553 |
NDRG1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1586452701 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586452965 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586453267 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586453329 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586453824 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586456278 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS1586456293 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS1586456350 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS1586456404 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS1586457060 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS1586457084 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS1586459408 |
THAP1
|
Health Risk |
Likely pathogenic |
Dystonic disorder, Dystonic disorder |
| RS1586459413 |
THAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Torsion dystonia 6, Torsion dystonia 6 |
| RS1586460329 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586462917 |
CHD7
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 5 with or without anosmia, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1586463029 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586464368 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS1586466948 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586468521 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1586472959 |
RELN
|
Health Risk |
Likely pathogenic |
Norman-Roberts syndrome, Norman-Roberts syndrome |
| RS1586479593 |
INTS8
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with cerebellar hypoplasia and spasticity, Neurodevelopmental disorder with cerebellar hypoplasia and spasticity |
| RS1586484463 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1586485406 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS1586485438 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS1586486170 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal dominant form |
| RS1586487826 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1586496726 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1586499614 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1586507590 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1586510615 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal dominant form |
| RS1586510870 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS1586514992 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1586515112 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1586540615 |
INTS8
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with cerebellar hypoplasia and spasticity, Neurodevelopmental disorder with cerebellar hypoplasia and spasticity |
| RS1586555859 |
PUF60
|
Health Risk |
Likely pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1586557065 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS1586558204 |
SLC52A2
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 2, Brown-Vialetto-van Laere syndrome 2 |
| RS1586561494 |
CYP11B1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1586565506 |
PUF60
|
Health Risk |
Likely pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1586573244 |
CYP11B2
|
Health Risk |
Pathogenic |
CYP11B2-related disorder, CYP11B2-related disorder |
| RS1586586381 |
DNAAF11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 19, Primary ciliary dyskinesia |
| RS1586590135 |
PUF60
|
Health Risk |
Pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1586595293 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS1586620121 |
CPSF1
|
Health Risk |
Pathogenic |
Myopia 27, Myopia 27 |
| RS1586635371 |
SMARCA2
|
Health Risk |
Likely pathogenic |
— |
| RS1586636643 |
TMEM70
|
Health Risk |
Pathogenic |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
| RS1586652047 |
SLC39A4
|
Health Risk |
Likely pathogenic |
— |
| RS1586657848 |
SMARCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Blepharophimosis-impaired intellectual development syndrome |
| RS1586660338 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1586660370 |
SMARCA2
|
Health Risk |
Pathogenic |
Intellectual disability, Blepharophimosis-impaired intellectual development syndrome |
| RS1586660381 |
SMARCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Blepharophimosis-impaired intellectual development syndrome |
| RS1586660389 |
SMARCA2
|
Health Risk |
Pathogenic |
Intellectual disability, Nicolaides-Baraitser syndrome |
| RS1586672470 |
DOCK8
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS1586681137 |
POMK
|
Health Risk |
Pathogenic |
Limb-girdle muscular dystrophy due to POMK deficiency, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1586681982 |
TONSL
|
Health Risk |
Pathogenic/Likely pathogenic |
Sponastrime dysplasia, Sponastrime dysplasia |
| RS1586686845 |
KCNV2
|
Health Risk |
Pathogenic |
cone dystrophy with supernormal rod electroretinogram, cone dystrophy with supernormal rod electroretinogram |
| RS1586686896 |
KCNV2
|
Health Risk |
Likely pathogenic |
cone dystrophy with supernormal rod electroretinogram, cone dystrophy with supernormal rod electroretinogram |
| RS1586687216 |
KCNV2
|
Health Risk |
Pathogenic |
cone dystrophy with supernormal rod electroretinogram, cone dystrophy with supernormal rod electroretinogram |
| RS1586687247 |
KCNV2
|
Health Risk |
Likely pathogenic |
cone dystrophy with supernormal rod electroretinogram, cone dystrophy with supernormal rod electroretinogram |
| RS1586687279 |
TONSL
|
Health Risk |
Pathogenic/Likely pathogenic |
Sponastrime dysplasia, Sponastrime dysplasia |
| RS1586692058 |
TONSL
|
Health Risk |
Pathogenic/Likely pathogenic |
Sponastrime dysplasia, Sponastrime dysplasia |
| RS1586692481 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Intellectual disability, Blepharophimosis-impaired intellectual development syndrome |
| RS1586692548 |
SMARCA2
|
Health Risk |
Pathogenic |
Intellectual disability, Blepharophimosis-impaired intellectual development syndrome |
| RS1586692551 |
SMARCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Blepharophimosis-impaired intellectual development syndrome |
| RS1586692857 |
KCNV2
|
Health Risk |
Likely pathogenic |
cone dystrophy with supernormal rod electroretinogram, cone dystrophy with supernormal rod electroretinogram |
| RS1586698317 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1586721515 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS1586744173 |
GLIS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neonatal diabetes mellitus with congenital hypothyroidism, Neonatal diabetes mellitus with congenital hypothyroidism |
| RS1586765219 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS1586787093 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Inborn genetic diseases |
| RS1586790519 |
RECQL4
|
Health Risk |
Likely pathogenic |
Baller-Gerold syndrome, Papillary renal cell carcinoma type 1 |
| RS1586791537 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1586791945 |
RECQL4
|
Health Risk |
Likely pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1586792875 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1586794015 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS1586794308 |
GDAP1
|
Health Risk |
Likely pathogenic |
— |
| RS1586794620 |
RECQL4
|
Health Risk |
Likely pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1586795055 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1586795216 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4A |
| RS1586795440 |
GDAP1
|
Health Risk |
Likely pathogenic |
— |
| RS1586795973 |
RECQL4
|
Health Risk |
Pathogenic/Likely pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |